Advertisement
Screener

CERO THERAPEUTICS HOLDINGS, INC. (CERO) Preferred Stock Dividends and Other Adjustments

1.1 / 5 stars · 4/18 Roast Me

CERO THERAPEUTICS HOLDINGS, INC. Preferred Stock Dividends and Other Adjustments

CERO THERAPEUTICS HOLDINGS, INC. (CERO) reported Preferred Stock Dividends and Other Adjustments of $24.70 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-22.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:PreferredStockDividendsAndOtherAdjustments · last filed 2025-08-22

  • CERO THERAPEUTICS HOLDINGS, INC. preferred stock dividends and other adjustments for the quarter ending 2025-06-30 was $24.70M.
  • CERO THERAPEUTICS HOLDINGS, INC. preferred stock dividends and other adjustments for the quarter ending 2025-03-31 was $264.14K.
Period endPreferred Stock Dividends and Other Adjustments 3 monthPreferred Stock Dividends and Other Adjustments 6 month
2025-06-30$24.70M
10-Q · filed 2025-08-22
$24.96M
10-Q · filed 2025-08-22
2025-03-31$264.14K
10-Q · filed 2025-05-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)United States$0.006B
AIM ImmunoTech Inc. (AIM)United States$0.006B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
VivoSim Labs, INC. (VIVS)United States$0.003B
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
IN8BIO, INC. (INAB)United States$0.012B-0.76
CURIS INC (CRIS)United States$0.002B-0.05